Indolocarbazole derivatives – a promising class of anticancer drugs
Open Access
- 11 December 2018
- journal article
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 17 (4) , 20-26
Abstract
The paper discusses the possible mechanisms of antitumor action of indolocarbazole derivatives. Here we present a data that show interaction drugs based on indolocarbazole derivatives with several intracellular targets and consequently activation different pathways of cell death. Also we present results of our studies on the mechanisms of antitumor action of compounds LCS-1006 and LCS-1208 synthesized in the N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia.Keywords
This publication has 32 references indexed in Scilit:
- Phase-II Trial of Rebeccamycin Analog, a Dual Topoisomerase-I and -II Inhibitor, in Relapsed “Sensitive” Small Cell Lung CancerJournal of Thoracic Oncology, 2012
- A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)Neuro-Oncology, 2012
- Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedulesInvestigational New Drugs, 2006
- The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT PathwayJournal of Investigative Dermatology, 2006
- Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell linesMolecular Cancer Therapeutics, 2006
- Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Blood, 2005
- Emerging DNA topoisomerase inhibitors as anticancer drugsExpert Opinion on Emerging Drugs, 2004
- Acyclic N‐(Azacycloalkyl)bisindolylmaleimides: Isozyme Selective Inhibitors of PKCβ.ChemInform, 2003
- Analogs of StaurosporineGeneral Pharmacology: The Vascular System, 1998